Researchers have identified how natural killer (NK) cells in the mouse placenta can cause a fetus to fail to grow in the womb or cause miscarriages.
They also identified several possible treatments in a paper published in the journal Nature Communications.
Fetal and neonatal alloimmune thrombocytopenia, or FNAIT, affects pregnant women and their unborn babies when the mother's immune system sees some of her fetus' cells as foreign and sends antibodies to attack and destroy those cells.
The researchers found that, in mice, the mother's FNAIT immune response also triggers the activation of natural killer cells that target cells with the father's proteins, including trophoblasts -- cells responsible for the placenta's development and growth.
Natural killer cells are a type of lymphocyte -- one of the subtypes of white blood cells in the immune system. They play a major role in defending the fetus against cells carrying viruses and those that are growing abnormally, providing protection from disease and developmental issues in the early stages of pregnancy.
This immune attack can cause the placenta to deform and can disrupt the flow of nutrients to the fetus, both of which may limit the baby's growth in the womb and increase the likelihood of miscarriage, said the senior author.
"Natural killer cells are normal in pregnancy and necessary for early placental development in humans and other mammals, but their number in placenta should decrease in the late stage of pregnancy," senior author said. "In our study, we found that natural killer cells were not decreased, but prevalent and active in cases of FNAIT."
FNAIT occurs in around one in every 1,000 live births, but it is likely much more common, said senior author, because this number does not include women with FNAIT who have miscarriages.
Researchers estimate two to three per cent of the population is at risk for FNAIT, and some reports estimate up to 30 per cent of affected fetuses miscarry, the authors wrote.
The same kind of blood-clotting in coronary arteries or blood vessels in the brain that causes heart attacks and strokes also happens in the placenta. The massive clotting can destroy the placenta, block blood flow to the fetus, which can lead to miscarriages.
Based on the findings of the new study, the authors found there were several methods that might effectively prevent FNAIT-related miscarriages by targeting natural killer cells.
The first treatment option is to use intravenous immunoglobulin G (IVIG), a blood product prepared from pools of plasma from more than 1,000 healthy donors. IVIG blocks the sensors of natural killer cells, disorienting them and preventing them from targeting placental cells, according to the authors. IVIG also decreases maternal anti-fetal antibodies, they said.
IVIG has already been approved to treat several autoimmune diseases, but would need to be used in high doses to effectively treat FNAIT, making it very expensive, said the senior author.
In the lab, the authors also tested other treatments including specifically targeting cell receptors to block the activation of natural killer cells. It will be less expensive because less of the protein is required for these treatments, and may be more efficient than IVIG. However, they have not yet been approved for clinical use in human FNAIT, said Dr. Ni.
Rates of reduced growth and miscarriage could also be decreased by removing natural killer cells from the body; however this is not a recommended treatment because of the essential role natural killer cells play in early placental development as well as in both the mother and fetus' immune systems.
More research will be needed to determine whether these new anti-natural killer cell treatments would be effective in humans, said the senior author.
http://www.stmichaelshospital.com/media/detail.php?source=hospital_news/2017/0809
Latest News
How protein synthesis in de…
By newseditor
Posted 22 Apr
Atlas of mRNA variants in d…
By newseditor
Posted 22 Apr
Mapping microbiome in metas…
By newseditor
Posted 22 Apr
Full-length mRNA packaged i…
By newseditor
Posted 22 Apr
Glucose-sensing mechanism t…
By newseditor
Posted 21 Apr
Other Top Stories
Epigenetic modulation using CRISPR/Cas9
Read more
Manipulating synaptic plasticity!
Read more
CellChat to analyze and infer cell-cell communications
Read more
Mechanism of membrane-tethered mitochondrial protein synthesis
Read more
Neuromodulation of the cerebellum restores movement in ataxia
Read more
Protocols
A programmable targeted pro…
By newseditor
Posted 23 Apr
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Publications
Neuronal activity rapidly r…
By newseditor
Posted 22 Apr
A perspective on muscle phe…
By newseditor
Posted 22 Apr
Foxp1 suppresses cortical a…
By newseditor
Posted 22 Apr
Single-cell long-read seque…
By newseditor
Posted 22 Apr
Unlocking potential: the ro…
By newseditor
Posted 22 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar